This change appears to be due to the WD and not from NAR itself, which may be attributable to hepatic metabolic adaptations associated with diet-induced obesity caused by the WD, which induces steatosis and low-grade inflammation. Here, CPSF4 is linked to obesity due to melanocortin 4 receptor deficiency.